From 2007 to 2015, Mylan CEO Heather Bresch saw her total compensation go from $2,453,456 to $18,931,068, a 671 percent increase. During the same period, the company raised EpiPen prices, with the average wholesale price going from $56.64 to $317.82, a 461 percent increase
The stock price more than tripled, going from $13.29 in 2007 to a high of $47.59 in 2016.
Between 2007 and 2015, Heather Bresch, CEO of Mylan, experienced a 671 percent increase in compensation, according to NBC News. Within the same time period, EpiPen wholesale prices rose on average from $56.64 to $317.82, about 461 percent.
In recent years, the lobbying efforts of Mylan also increased, resulting new recommendations by the FDA for the product to be sold in packs of two and to be prescribed for at-risk patients. Not only this, but NBC also reported that Heather Bresch is the daughter of Senator Joe Manchin.
The price increases have resulted in concerned parents about the power of pharmaceutical companies and caused many to find cheaper outlets for the necessary drug.
“Patients are instead buying abroad where the EpiPen is cheaper, and resorting to other devices that deliver epinephrine, including DIY syringes.”